Chippenham, UK – 24 January 2007: Vectura Group plc (LSE: VEC) (“Vectura”) today announces that the Aspirair® dry powder inhaler has received CE mark certification. This certificate confirms that the Aspirair inhaler meets all regulatory requirements for a class IIb medical device within Europe . The inhaler will now bear the CE mark of an approved device.
